Recombinant human TGF beta 3 protein (Active) is a Human Fragment protein, in the 301 to 412 aa range, expressed in Escherichia coli, with >98% purity and suitable for SDS-PAGE, FuncS, HPLC, WB.
A L D T N Y C F R N L E E N C C V R P L Y I D F R Q D L G W K W V H E P K G Y Y A N F C S G P C P Y L R S A D T T H S T V L G L Y N T L N P E A S A S P C C V P Q D L E P L T I L Y Y V G R T P K V E Q L S N M V V K S C K C S
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application FuncS | Reactivity Reacts | Dilution info - | Notes - |
Application HPLC | Reactivity Reacts | Dilution info - | Notes - |
Application WB | Reactivity Reacts | Dilution info - | Notes ab52313 can be used as a WB positive control in conjunction with Anti-TGF beta 3 antibody ab15537. |
Select an associated product type
Transforming growth factor beta-3 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-3 (TGF-beta-3) chains, which constitute the regulatory and active subunit of TGF-beta-3, respectively. Latency-associated peptide. Required to maintain the Transforming growth factor beta-3 (TGF-beta-3) chain in a latent state during storage in extracellular matrix (By similarity). Associates non-covalently with TGF-beta-3 and regulates its activation via interaction with 'milieu molecules', such as LTBP1 and LRRC32/GARP, that control activation of TGF-beta-3 (By similarity). Interaction with integrins results in distortion of the Latency-associated peptide chain and subsequent release of the active TGF-beta-3 (By similarity). Transforming growth factor beta-3: Multifunctional protein that regulates embryogenesis and cell differentiation and is required in various processes such as secondary palate development (By similarity). Activation into mature form follows different steps: following cleavage of the proprotein in the Golgi apparatus, Latency-associated peptide (LAP) and Transforming growth factor beta-3 (TGF-beta-3) chains remain non-covalently linked rendering TGF-beta-3 inactive during storage in extracellular matrix (By similarity). At the same time, LAP chain interacts with 'milieu molecules', such as LTBP1 and LRRC32/GARP that control activation of TGF-beta-3 and maintain it in a latent state during storage in extracellular milieus (By similarity). TGF-beta-3 is released from LAP by integrins: integrin-binding results in distortion of the LAP chain and subsequent release of the active TGF-beta-3 (By similarity). Once activated following release of LAP, TGF-beta-3 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal (By similarity).
Transforming growth factor beta-3 proprotein, TGFB3
Recombinant human TGF beta 3 protein (Active) is a Human Fragment protein, in the 301 to 412 aa range, expressed in Escherichia coli, with >98% purity and suitable for SDS-PAGE, FuncS, HPLC, WB.
The ED50 was determined by cytotoxicity assay using the WHO standard 98/608 as a direct comparison is < 0.05 ng/ml, corresponding to a specific activity of > 2 x 108 units/mg.
Constituents: 20% Ethanol, 0.06% Acetic acid buffer
>98% HPLC analyses
Transforming growth factor beta-3 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-3 (TGF-beta-3) chains, which constitute the regulatory and active subunit of TGF-beta-3, respectively.
Belongs to the TGF-beta family.
Transforming growth factor beta-3 proprotein: The precursor proprotein is cleaved in the Golgi apparatus to form Transforming growth factor beta-3 (TGF-beta-3) and Latency-associated peptide (LAP) chains, which remain non-covalently linked, rendering TGF-beta-3 inactive.
This product is an active protein and may elicit a biological response in vivo, handle with caution.
This product is manufactured by BioVision, an Abcam company and was previously called 4344 TGF-beta3, human recombinant. 4344-5 is the same size as the 5 μg size of ab52313.
Endotoxin level: <0.1 ng/μg.
Centrifuge the vial prior to opening.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Cytotoxicity Assay of ab52313.
All lanes: Western blot - Anti-TGF beta 3 antibody (Anti-TGF beta 3 antibody ab15537) at 1/200 dilution
All lanes: Western blot - Recombinant human TGF beta 3 protein (Active) (ab52313) at 0.01 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (Goat Anti-Rabbit IgG H&L (HRP) preadsorbed ab97080) at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 47 kDa
Exposure time: 30s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com